March 1, 2024
Poultry Diagnostics Market

Rising Trends in Molecular Diagnostics anticipate to open up the new avenue for Poultry Diagnostics Market

The poultry diagnostics market is estimated to be valued at US$ 536.7 Mn or in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The poultry diagnostics market involves testing poultry birds for infectious diseases. Common diseases include avian influenza, Newcastle disease, Salmonellosis, and Marek’s disease. Molecular diagnostic tests based on polymerase chain reaction (PCR) are commonly used to detect pathogens. ELISA (enzyme-linked immunosorbent assay) tests are also used to detect antibodies against pathogens. These diagnostic methods help poultry farmers to quickly identify diseases and prevent their spread to other birds. Early detection is important for effective treatment and control of outbreaks.

Market Dynamics:

The growth of the poultry diagnostics market is driven by rising demand for poultry meat and eggs globally. According to FAO, per capita consumption of poultry meat increased from 15.8 kg in 2012 to 16.8 kg in 2019. Rapid urbanization and rising incomes in developing countries are contributing to this rising demand. Moreover, increasing threat of zoonotic diseases is also fueling the need for reliable diagnostic testing of poultry flocks. Molecular diagnostic tests provide accurate and timely results, enabling prompt treatment. Their rising adoption compared to conventional diagnostics is further propelling market growth. However, high costs associated with these tests could hinder market expansion to some extent.

Segment Analysis:

The global poultry diagnostics market is segmented into tests, disease and services. Among them, disease type is further segmented into Avian Influenza, Avian Salmonellosis, Avian Pasteurellosis, Avian Mycoplasmosis, Newcastle Disease and others. The avian influenza segment dominates the market due to the seasonal outbreak of avian influenza which results in higher demand for screening and diagnosis of avian influenza.

PEST Analysis:

  • Political: Avian diseases can spread rapidly impacting poultry farms and trade. Hence, governments develop regulations regarding screening, vaccination, and import/export of poultry products to control cross-border diseases spread.
  • Economic: Growing global meat consumption is fueling expansion of poultry farming which is driving demand for diagnostic testing to monitor bird health and prevent costly disease outbreaks.
  • Social: Rising health awareness is increasing screening of poultry meat & eggs for zoonotic diseases before human consumption ensuring food safety.
  • Technological: Advancements in molecular, immunoassay and PCR-based techniques enable rapid, accurate on-farm disease diagnosis reducing treatment time and financial losses.

Key Takeaways:

The Global Poultry Diagnostics Market Size is expected to witness high growth, exhibiting CAGR of 11% over the forecast period, due to increasing demand for screened poultry products ensuring food safety. The Asia Pacific region is expected to dominate the market due to rising poultry meat consumption and growing occurrence of avian diseases. Key players operating in the poultry diagnostics market include Zoetis, Thermo Fisher Scientific Inc., Baltivet, Bioingentech, Devex, BioChek, QIAGEN, Bioneer Corporation, Megacor Diagnostik GmbH, Merck & Co., Inc., IdentiGEN, Abaxis, BIOMERIEUX, Transasia Bio-Medicals, Boehringer Ingelheim International GmbH, EW Group Ltd., and Hygiena, LLC.

The global poultry diagnostics market size for 2023 is estimated to be US$ 536.7 Mn. Regional analysis shows that Asia Pacific dominated the global market owing to rising expansion of poultry farming to meet the rising demand for poultry meat and increasing incidence of avian influenza and salmonellosis. Key players in the market are focusing on developing rapid point-of-care devices and advanced molecular diagnostic kits for on-farm disease detection to gain competitive edge.

*Note:
1.  Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it